EUR 1.6 million for UKE's open access publications

17 November 2022
German Research Foundation to fund publications from 2023

The German Research Foundation (DFG) has earmarked EUR 1.6 million in funds for open access publications at the University Hospital Hamburg-Eppendorf (UKE) from 2023 for three years, a press release said Tuesday (November 8, 2022). Termed the "publication of the future" by the German Ministry of Education and Research, the measure should ease networking between scientists and raise the visibility of results and make knowledge more accessible.

Costs of open access publications

Launched with the Associate Dean for Research and the Central Medical Library,  Prof. Dr. Petra Arck, Dean of Research at UKE, noted: "Freely accessible research results are gaining importance in scientific and social discussions." DFG's funding enables researchers to publish in open access form, which is usually quite costly. Researchers can also apply for grants in the future. Open access goes beyond scientific publications and includes freely accessible educational materials or educational resources as well as open source software which comes with publicly-available source codes.


Sources and further information

Similar articles

Funding for UKE Collaborative Research Center extended until 2026

EUR 15.8 million approved - great success for medical research in Hamburg

Four prizes for top research at University Hospital Hamburg-Eppendorf

UKE's talented young medical professionals win Germany's oldest medical prize

EU funding 3D printing of medicine and implants at UKE

Scientists test 3D printing and AI

UKE Project: Recognising complications early using AI

Intensive care patients with brain disease: How an AI prognosis program is able to identify critical phases ahead of time
The Consent Management Platform ( we use could not be loaded. This can happen if AdBlockers incorrectly block this URL. Some features such as maps, proximity search or forms, cannot be used this way. To use these features, please deactivate your AdBlocker or allow access to *